Summary
65 / 100 · Bulios Score
What speaks for it
- It bought back its own shares for $1.65B in the last fiscal year, 7.7% of its market value.
- It has been profitable 6 years in a row.
What to watch
- It cut its dividend by 28% last year.
- The share price is above the Bulios Fair Price.
- Revenue fell by 4.4% a year over the last 3 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 4.6 CAD for 1 CAD of yearly profit. Over the last five years it was 4.9 CAD on average.
Valuation in detailIs it growing?
It is shrinkingRevenue (CAD)
Diluted EPS (CAD)
- Analyst estimate
Revenue fell by 8.4% a year over 5 years. Over the last 3 years it fell by 4.4% a year. Earnings per share grew by 3.3% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 CAD of revenue goes
- Cost of sales 38 CAD
- Sales and administration 43 CAD
- Taxes and other 7.6 CAD
- Net profit 12 CAD
Net profit, industry median (Insurance - Life) 9.5 CAD
Out of every 100 CAD of revenue, 12 CAD is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
High, safe- Yield
- 5.51%
- Paid out of profit
- 25%
You receive $0.94 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.